Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $1.55B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Arca Biopharma USD 1.34B 1.1B Aug/2026
Biogen USD 31.9B 5B Jun/2026
Brainstorm Cell Therapeutics USD 43M 32M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 60.19B 4.3B Aug/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Otsuka Holdings JPY 5.87T 111.31B Jun/2026
Pfizer USD 153.17B 14.73B Aug/2026
United Therapeutics USD 24.42B 1.42B Aug/2026